期刊
LASERS IN MEDICAL SCIENCE
卷 37, 期 3, 页码 1415-1425出版社
SPRINGER LONDON LTD
DOI: 10.1007/s10103-021-03451-6
关键词
Transplantation; Autologous; Adipose-derived mesenchymal stem cells; Diabetes mellitus; Diabetic foot ulcer; Pretreatment; Stem cell preconditioning; Wounds
This systematic review outlined the use of diabetic autologous adipose-derived mesenchymal stem cells (DAAD-MSCs) in treating wounds and ulcers in animal models and diabetic patients. Preconditioning diabetic adipose-derived mesenchymal stem cells (DAD-MSCs) with different agents showed varying outcomes in treating diabetic foot ulcers (DFUs) and wounds. The study highlighted the conflicting results on the effects of DAAD-MSCs on wound healing in animals and diabetic patients, suggesting the need for further research.
The primary goal of this systematic review article was to provide an outline of the use of diabetic autologous adipose-derived mesenchymal stem cells (DAAD-MSCs) in the treatment of wounds and ulcers in animal models and patients with diabetes mellitus (DM). The secondary goal was to present the outcomes of pretreatment of diabetic adipose-derived mesenchymal stem cells (DAD-MSCs) with probable different agents in the treatment of diabetic foot ulcers (DFUs) and wounds. In view of possible clinical applications of AD-MSC-mediated cell therapy for DFUs, it is essential to evaluate the influence of DM on AD-MSC functions. Nevertheless, there are conflicting results about the effects of DAAD-MSCs on accelerating wound healing in animals and DM patients. Multistep research of the MEDLINE, PubMed, Embase, Clinicaltrials.gov, Scopus database, and Cochrane databases was conducted for abstracts and full-text scientific papers published between 2000 and 2020. Finally, 5 articles confirmed that the usage of allogeneic or autologous AD-MSCs had encouraging outcomes on diabetic wound healing. One study reported that DM changes AD-MSC function and therapeutic potential, and one article recommended that the pretreatment of diabetic allogeneic adipose-derived mesenchymal stem cells (DAlD-MSCs) was more effective in accelerating diabetic wound healing. Recently, much work has concentrated on evolving innovative healing tactics for hastening the repair of DFUs. While DM alters the intrinsic properties of AD-MSCs and impairs their function, one animal study showed that the pretreatment of DAlD-MSCs in vitro significantly increased the function of DAlD-MSCs compared with DAlD-MSCs without any treatment. Preconditioning diabetic AD-MSCs with pretreatment agents like photobiomodulation (PBM) significantly hastened healing in delayed-healing wounds. It is suggested that further animal and human studies be conducted in order to provide more documentation. Hopefully, these outcomes will help the use of DAAD-MSCs plus PBM as a routine treatment protocol for healing severe DFUs in DM patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据